Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy

por Sho, Takuya, Morikawa, Kenichi, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Shigesawa, Taku, Kimura, Mugumi, Nakai, Masato, Suda, Goki, Natsuizaka, Mitsuteru, Ogawa, Koji, Sakamoto, Naoya
Publicado 2021

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma

por Nakai, Masato, Morikawa, Kenichi, Hosoda, Shunichi, Yoshida, Sonoe, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Ohara, Masatsugu, Sho, Takuya, Suda, Goki, Ogawa, Koji, Sakamoto, Naoya
Publicado 2022

Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients

por Nakai, Masato, Suda, Goki, Ogawa, Koji, Yoshida, Sonoe, Hosoda, Shunichi, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Shigesawa, Taku, Ohara, Masatsugu, Sho, Takuya, Morikawa, Kenichi, Sakamoto, Naoya
Publicado 2022

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

por Nakai, Masato, Yamamoto, Yoshiya, Baba, Masaru, Suda, Goki, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Shigesawa, Taku, Suzuki, Kazuharu, Nakamura, Akihisa, Sho, Takuya, Morikawa, Kenichi, Ogawa, Koji, Furuya, Ken, Sakamoto, Naoya
Publicado 2022

Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI

por Kubo, Akinori, Suda, Goki, Kimura, Megumi, Maehara, Osamu, Tokuchi, Yoshimasa, Kitagataya, Takashi, Ohara, Masatsugu, Yamada, Ren, Shigesawa, Taku, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Publicado 2021

Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma

por Ohara, Masatsugu, Suda, Goki, Kohya, Risako, Sasaki, Takashi, Yoda, Tomoka, Yoshida, Sonoe, Fu, Qingjie, Yang, Zijian, Hosoda, Shunichi, Maehara, Osamu, Ohnishi, Shunsuke, Tokuchi, Yoshimasa, Kitagataya, Takashi, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Ogawa, Koji, Sakamoto, Naoya
Publicado 2023

Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma

por Shigesawa, Taku, Suda, Goki, Kimura, Megumi, Maehara, Osamu, Tokuchi, Yoshimasa, Kubo, Akinori, Yamada, Ren, Furuya, Ken, Baba, Masaru, Kitagataya, Takashi, Suzuki, Kazuharu, Ohara, Masatsugu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Sakamoto, Naoya
Publicado 2021

Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C

por Kawagishi, Naoki, Suda, Goki, Kimura, Megumi, Maehara, Osamu, Yamada, Ren, Tokuchi, Yoshimasa, Kubo, Akinori, Kitagataya, Takashi, Shigesawa, Taku, Suzuki, Kazuharu, Ohara, Masatsugu, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Kudo, Yusuke, Nishida, Mutsumi, Sakamoto, Naoya
Publicado 2021

Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma

por Yang, Zijian, Suda, Goki, Maehara, Osamu, Ohara, Masatsugu, Yoda, Tomoka, Sasaki, Takashi, Kohya, Risako, Yoshida, Sonoe, Hosoda, Shunichi, Tokuchi, Yoshimasa, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Publicado 2023

Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C

por Kawagishi, Naoki, Suda, Goki, Yamamoto, Yoshiya, Baba, Masaru, Furuya, Ken, Maehara, Osamu, Ohnishi, Shunsuke, Yoshida, Sonoe, Fu, Qingjie, Yang, Zijian, Hosoda, Shunichi, Tokuchi, Yoshimasa, Kitagataya, Takashi, Ohara, Masatsugu, Suzuki, Kazuharu, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Ogawa, Koji, Sakamoto, Naoya
Publicado 2023

Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma

por Kohya, Risako, Suda, Goki, Ohara, Masatsugu, Sasaki, Takashi, Yoda, Tomoka, Sakurai, Naofumi, Yoshida, Sonoe, Fu, Qingjie, Yang, Zijian, Hosoda, Shunichi, Maehara, Osamu, Ohnishi, Shunsuke, Tokuchi, Yoshimasa, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Ogawa, Koji, Sakamoto, Naoya
Publicado 2023

Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia

por Yoshida, Sonoe, Suda, Goki, Ohara, Masatsugu, Fu, Qingjie, Yang, Zijian, Hosoda, Shunichi, Kimura, Megumi, Akinori, Kubo, Tokuchi, Yoshimasa, Yamada, Ren, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Maehara, Osamu, Ohnishi, Shunsuke, Sakamoto, Naoya
Publicado 2021

Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals

por Tokuchi, Yoshimasa, Suda, Goki, Kimura, Megumi, Maehara, Osamu, Kitagataya, Takashi, Kubo, Akinori, Yoshida, Sonoe, Fu, Qingjie, Yang, Zijian, Hosoda, Shunichi, Ohara, Masatsugu, Yamada, Ren, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Publicado 2021

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma

por Yang, Zijian, Suda, Goki, Maehara, Osamu, Ohara, Masatsugu, Yoshida, Sonoe, Hosoda, Shunichi, Kimura, Megumi, Kubo, Akinori, Tokuchi, Yoshimasa, Fu, Qingjie, Yamada, Ren, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Publicado 2022

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy

por Kawagishi, Naoki, Suda, Goki, Sakamori, Ryotaro, Matsui, Takeshi, Onozawa, Masahiro, Yang, Zijian, Yoshida, Sonoe, Ohara, Masatsugu, Kimura, Megumi, Kubo, Akinori, Maehara, Osamu, Fu, Qingjie, Hosoda, Shunichi, Tokuchi, Yoshimasa, Suzuki, Kazuharu, Nakai, Masato, Sho, Takuya, Morikawa, Kenichi, Natsuizaka, Mitsuteru, Ogawa, Koji, Sakai, Hajime, Ohnishi, Shunsuke, Baba, Masaru, Takehara, Tetsuo, Sakamoto, Naoya
Publicado 2022

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment

por Hosoda, Shunichi, Suda, Goki, Sho, Takuya, Ogawa, Koji, Kimura, Megumi, Yang, Zijian, Yoshida, Sonoe, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Maehara, Osamu, Ohnishi, Shunsuke, Nakamura, Akihisa, Yamada, Ren, Ohara, Masatsugu, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Yamamoto, Yoshiya, Suzuki, Kazuharu, Izumi, Takaaki, Meguro, Takashi, Terashita, Katsumi, Ito, Jun, Miyagishima, Takuto, Sakamoto, Naoya
Publicado 2022

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrav...

por Sho, Takuya, Suda, Goki, Yamamoto, Yoshiya, Furuya, Ken, Baba, Masaru, Ogawa, Koji, Kubo, Akinori, Tokuchi, Yoshimasa, Fu, Qingjie, Yang, Zijian, Kimura, Megumi, Kitagataya, Takashi, Maehara, Osamu, Ohnishi, Shunsuke, Nakamura, Akihisa, Yamada, Ren, Ohara, Masatsugu, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Suzuki, Kazuharu, Izumi, Takaaki, Meguro, Takashi, Terashita, Katsumi, Takagi, Tomofumi, Ito, Jun, Kobayashi, Tomoe, Miyagishima, Takuto, Sakamoto, Naoya
Publicado 2022